Assembly Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	611	538	100	54	63	112
Market Cap Growth	221.76%	436.32%	85.89%	-14.91%	-43.14%	-44.18%
Enterprise Value	293	308	7	9	-41	-71
Last Close Price	30.01	34.01	15.78	9.84	15.60	27.96
PS Ratio	8.16	7.44	3.52	7.53	-	17.83
PB Ratio	1.95	2.60	3.01	1.31	0.77	0.66
P/TBV Ratio	2.00	2.60	3.01	1.31	0.77	0.66
P/FCF Ratio	-	-	-	2.40	-	-
P/OCF Ratio	-	-	-	2.37	-	-
EV/Sales Ratio	3.91	4.26	0.24	1.21	-	-
EV/FCF Ratio	-	-	-	0.39	-	-
Debt / Equity Ratio	0.01	0.01	0.09	0.06	0.04	0.04
Debt / FCF Ratio	-	-	-	0.10	-	-
Net Debt / Equity Ratio	-1.04	-1.19	-3.27	-3.11	-1.07	-0.99
Net Debt / EBITDA Ratio	36.60	20.48	2.41	1.99	0.95	1.83
Net Debt / FCF Ratio	8.25	5.96	2.13	-5.69	1.04	1.74
Asset Turnover	0.36	0.38	0.22	0.06	-	0.03
Quick Ratio	13.79	5.14	2.35	3.33	5.70	9.14
Current Ratio	13.99	5.22	2.42	3.41	5.95	9.59
Return on Equity (ROE)	-0.03%	-5.10%	-107.92%	-98.95%	-74.00%	-63.42%
Return on Assets (ROA)	-2.67%	-4.02%	-22.18%	-33.87%	-39.70%	-24.35%
Return on Capital Employed (ROCE)	-2.90%	-5.80%	-63.60%	-66.20%	-108.80%	-52.80%
Earnings Yield	-0.01%	-1.14%	-40.06%	-113.47%	-146.80%	-116.44%
FCF Yield	-6.31%	-7.65%	-50.99%	41.68%	-133.35%	-86.53%
Buyback Yield / Dilution	-133.27%	-86.71%	-31.18%	-13.47%	-11.85%	-22.17%

SEC Filings: 10-K · 10-Q